当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 现金流量表

尔康制药

(300267)

  

流通市值:45.80亿  总市值:66.42亿
流通股本:14.22亿   总股本:20.63亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金518,203,459.22239,409,879.331,148,869,063.321,166,866,554.16
  收到的税费返还7,192,033.442,923,821.067,788,046.817,425,034.2
  收到其他与经营活动有关的现金10,556,731.8321,066,912.82335,790,016.0925,800,325.68
  经营活动现金流入小计535,952,224.49263,400,613.211,492,447,126.221,200,091,914.04
  购买商品、接受劳务支付的现金513,575,360.73172,747,428.58620,209,903.93769,801,663.55
  支付给职工以及为职工支付的现金87,453,877.0549,507,464.81152,239,583.9119,576,739.79
  支付的各项税费23,082,698.415,908,780.0152,051,865.5637,401,990.02
  支付其他与经营活动有关的现金65,889,807.0735,155,081.66410,260,801.5261,626,673.33
  经营活动现金流出小计690,001,743.25273,318,755.061,234,762,154.91988,407,066.69
  经营活动产生的现金流量净额-154,049,518.76-9,918,141.85257,684,971.31211,684,847.35
二、投资活动产生的现金流量:
  收回投资收到的现金310,000,000170,000,0001,110,000,000740,000,000
  取得投资收益收到的现金524,826.5323,244.33,775,387.983,331,200.04
  处置固定资产、无形资产和其他长期资产收回的现金净额1,525,561.4115,672.971,737,885.731,362,974.33
  投资活动现金流入小计312,050,387.91170,338,917.271,115,513,273.71744,694,174.37
  购建固定资产、无形资产和其他长期资产支付的现金78,807,814.0134,797,831.2163,980,195.38107,779,667.07
  投资支付的现金240,000,000170,000,0001,080,000,000825,000,000
  支付其他与投资活动有关的现金19,066.24---
  投资活动现金流出小计318,826,880.25204,797,831.21,243,980,195.38932,779,667.07
  投资活动产生的现金流量净额-6,776,492.34-34,458,913.93-128,466,921.67-188,085,492.7
三、筹资活动产生的现金流量:
  吸收投资收到的现金750,000750,000--
  取得借款收到的现金472,200,000269,000,000671,337,821463,987,821
  收到其他与筹资活动有关的现金200,000,00086,000,000278,600,000228,600,000
  筹资活动现金流入小计672,950,000355,750,000949,937,821692,587,821
  偿还债务支付的现金334,397,821136,000,000597,700,000457,700,000
  分配股利、利润或偿付利息支付的现金5,286,155.573,329,283.3311,092,503.999,430,610.04
  支付其他与筹资活动有关的现金323,349,224.71173,739,273.36372,684,503.86258,597,451.52
  筹资活动现金流出小计663,033,201.28313,068,556.69981,477,007.85725,728,061.56
  筹资活动产生的现金流量净额9,916,798.7242,681,443.31-31,539,186.85-33,140,240.56
四、汇率变动对现金及现金等价物的影响-382,825.31-545,998.75-3,364,598.62-2,347,103.42
五、现金及现金等价物净增加额-151,292,037.69-2,241,611.2294,314,264.17-11,887,989.33
  加:期初现金及现金等价物余额584,223,288.95584,223,288.95489,909,024.78489,909,024.78
  期末现金及现金等价物余额432,931,251.26581,981,677.73584,223,288.95478,021,035.45
补充资料:
  净利润33,887,289.91--399,311,259.91-
  资产减值准备2,813,744.34-356,982,143.17-
  固定资产和投资性房地产折旧65,882,512.94-151,579,107.31-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧65,882,512.94-151,579,107.31-
  无形资产摊销9,590,514.8-22,909,486.63-
  长期待摊费用摊销1,624,214.86-3,445,357.31-
  处置固定资产、无形资产和其他长期资产的损失278,275.91--313,748.98-
  固定资产报废损失478.9-572,037.41-
  财务费用5,896,134.82-8,385,944.34-
  投资损失-300,898.51-18,168,794.63-
  递延所得税5,809,832.34-29,567,995.37-
  其中:递延所得税资产减少7,413,473.53-30,143,847.78-
    递延所得税负债增加-1,603,641.19--575,852.41-
  存货的减少-240,035,728.11-42,034,563.72-
  经营性应收项目的减少-27,596,187.9-2,482,707.86-
  经营性应付项目的增加4,388,365.76-27,712,497.51-
  其他-19,926,316.34--12,991,577.09-
  现金的期末余额432,931,251.26-584,223,288.95-
  减:现金的期初余额584,223,288.95-489,909,024.78-
  现金及现金等价物的净增加额-151,292,037.69-94,314,264.17-
公告日期2026-08-272026-04-242026-04-232025-10-30
审计意见(境内)标准无保留意见
TOP↑